BioMed X Fact Sheet
Learn more about the facts and figures of our BioMed X Institute.
Learn more about the facts and figures of our BioMed X Institute.
The team’s main objective is to understand the molecular mechanisms governing immune senescence and metabolic dysfunction in immune cells that are shared in autoimmunity and neuroinflammation.
The project’s cores are to develop a ligand specific for a target cell and establish quantitative assessment methods to monitor macromolecular drug delivery across the intestinal epithelial barrier.
The core of the project will be the development of a first in kind synovium-in-a-dish assay for systematic monitoring of macrophage functions.
Who We Are
Our management and project teams are regularly represented at events and report there about BioMed X and our ongoing research.
For us at BioMed X, publishing the results of our research projects in peer-reviewed journals is key. We also share results at national and international meetings and workshops. We think this is vital to building collaborations and stimulating cross-fertilization of ideas and methods.
At the BioMed X Institute, we are working with different state-of-the-art research tools and methods, emerging from the different research projects. As a Special Interest Group, we continuously grow our internal spectrum of laboratory tools and methods.
Fellowships at BioMed X are limited to a defined project term. During this period, all fellows focus their attention on biomedical research as well as personal growth in order to get ready for their next big challenge in academia, industry or a startup. The Special Interest Group “Career Development” is a grassroots initiative of BioMed X fellows organizing events and training courses.
Completed Projects · Oncology Team IMT Immunosuppressive Microenvironment of Tumors Solid tumors are complex microenvironments composed of cancer and immune cells that interact through various regulatory networks. Although CD8 T-cells may recognize and kill tumor cells, their function is impaired by cells such as regulatory T-cells, tumor-associated macrophages (TAM), and myeloid-derived suppresso…
Since 2013 we have started 20 research groups and successfully completed 12 projects. After a project term of 5 years, all data, materials, and intellectual property rights are transferred to the sponsoring partners.
The main objective of the IEB group is to identify key molecular mechanisms at intestinal epithelial-immune cells interface, in order to identify and develop new therapeutic targets for intestinal barrier loss in autoimmune diseases that will improve patient outcomes.
The team is interested in identifying key molecular and cellular mechanisms at the pathogen-host interface which could be exploited as potential targets for the treatment of multiple chronic inflammatory diseases.
Accelerate the pace of innovation in biomedical research. Become a partner and join the BioMed X Institute.
We are a team of highly diverse people from many different countries working on the same ambitious goals.